322 related articles for article (PubMed ID: 26213802)
21. N-Acetyl-D-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: Synthesis, characterization and in vitro evaluation.
Tian B; Ding Y; Han J; Zhang J; Han Y; Han J
Colloids Surf B Biointerfaces; 2015 Jun; 130():246-54. PubMed ID: 25921641
[TBL] [Abstract][Full Text] [Related]
22. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
[TBL] [Abstract][Full Text] [Related]
23. Porous Covalent Triazine Polymer as a Potential Nanocargo for Cancer Therapy and Imaging.
Rengaraj A; Puthiaraj P; Haldorai Y; Heo NS; Hwang SK; Han YK; Kwon S; Ahn WS; Huh YS
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8947-55. PubMed ID: 26998679
[TBL] [Abstract][Full Text] [Related]
24. Polyphosphoester-based nanoparticles with viscous flow core enhanced therapeutic efficacy by improved intracellular drug release.
Ma YC; Wang JX; Tao W; Qian HS; Yang XZ
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16174-81. PubMed ID: 25188541
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles generated by PEG-Chrysin conjugates for efficient anticancer drug delivery.
Zheng H; Li S; Pu Y; Lai Y; He B; Gu Z
Eur J Pharm Biopharm; 2014 Aug; 87(3):454-60. PubMed ID: 24691159
[TBL] [Abstract][Full Text] [Related]
26. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
[TBL] [Abstract][Full Text] [Related]
27. Degradable ketal-based block copolymer nanoparticles for anticancer drug delivery: a systematic evaluation.
Louage B; Zhang Q; Vanparijs N; Voorhaar L; Vande Casteele S; Shi Y; Hennink WE; Van Bocxlaer J; Hoogenboom R; De Geest BG
Biomacromolecules; 2015 Jan; 16(1):336-50. PubMed ID: 25490543
[TBL] [Abstract][Full Text] [Related]
28. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic nanocarriers with hydrogen peroxide-triggered drug release for cancer treatment.
Liu J; Pang Y; Zhu Z; Wang D; Li C; Huang W; Zhu X; Yan D
Biomacromolecules; 2013 May; 14(5):1627-36. PubMed ID: 23510441
[TBL] [Abstract][Full Text] [Related]
30. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
31. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
32. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
[TBL] [Abstract][Full Text] [Related]
33. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130
[TBL] [Abstract][Full Text] [Related]
34. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
35. Self-regulated multifunctional collaboration of targeted nanocarriers for enhanced tumor therapy.
Gao H; Cheng T; Liu J; Liu J; Yang C; Chu L; Zhang Y; Ma R; Shi L
Biomacromolecules; 2014 Oct; 15(10):3634-42. PubMed ID: 25308336
[TBL] [Abstract][Full Text] [Related]
36. Polymer micelle with pH-triggered hydrophobic-hydrophilic transition and de-cross-linking process in the core and its application for targeted anticancer drug delivery.
Fan J; Zeng F; Wu S; Wang X
Biomacromolecules; 2012 Dec; 13(12):4126-37. PubMed ID: 23145920
[TBL] [Abstract][Full Text] [Related]
37. pH-responsive zwitterionic polypeptide as a platform for anti-tumor drug delivery.
Liu N; Han J; Zhang X; Yang Y; Liu Y; Wang Y; Wu G
Colloids Surf B Biointerfaces; 2016 Sep; 145():401-409. PubMed ID: 27232303
[TBL] [Abstract][Full Text] [Related]
38. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
[TBL] [Abstract][Full Text] [Related]
39. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin-Stitched Polysaccharide Vesicles for Synergistic Cancer Therapy of Triple Antagonistic Drugs.
Deshpande NU; Jayakannan M
Biomacromolecules; 2017 Jan; 18(1):113-126. PubMed ID: 28064505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
